id	sid	eid	entity	type
ajlm-2723	1	1	deep madkaiker department	ORG
ajlm-2723	1	2	tata memorial centre	ORG
ajlm-2723	1	3	national institute	ORG
ajlm-2723	1	4	mumbai	GPE
ajlm-2723	1	5	india department	ORG
ajlm-2723	1	6	kasturba medical college	ORG
ajlm-2723	1	7	manipal	GPE
ajlm-2723	1	8	manipal academy	ORG
ajlm-2723	1	9	manipal	GPE
ajlm-2723	1	10	karnataka	GPE
ajlm-2723	1	11	india	GPE
ajlm-2723	1	12	shashank ojha department	ORG
ajlm-2723	1	13	tata memorial centre	ORG
ajlm-2723	1	14	national institute	ORG
ajlm-2723	1	15	mumbai	GPE
ajlm-2723	1	16	india	GPE
ajlm-2723	1	17	tata memorial centre	ORG
ajlm-2723	1	18	national institute	ORG
ajlm-2723	1	19	mumbai	GPE
ajlm-2723	1	20	india kalpesh chawan department of transfusion	ORG
ajlm-2723	1	21	tata memorial centre	ORG
ajlm-2723	1	22	national institute	ORG
ajlm-2723	1	23	mumbai	GPE
ajlm-2723	1	24	india	GPE
ajlm-2723	1	25	chawan k.	PERSON
ajlm-2723	1	26	western india	LOC
ajlm-2723	2	1	afr j	PERSON
ajlm-2723	3	1	2025;14(1	CARDINAL
ajlm-2723	4	1	western india	LOC
ajlm-2723	4	2	shashank ojha	PERSON
ajlm-2723	4	3	arunkumar n	PERSON
ajlm-2723	4	4	kalpesh chawan	ORG
ajlm-2723	4	5	10	CARDINAL
ajlm-2723	4	6	dec. 2024	DATE
ajlm-2723	4	7	28	CARDINAL
ajlm-2723	4	8	mar. 2025	DATE
ajlm-2723	4	9	25 june 2025	DATE
ajlm-2723	5	1	2025	CARDINAL
ajlm-2723	11	1	two	CARDINAL
ajlm-2723	12	1	ecs	ORG
ajlm-2723	12	2	mumbai	GPE
ajlm-2723	12	3	india	GPE
ajlm-2723	12	4	the period january 2015 to december 2019	DATE
ajlm-2723	13	1	fresenius	ORG
ajlm-2723	13	2	macopharma	PERSON
ajlm-2723	14	1	500	CARDINAL
ajlm-2723	15	1	ec	ORG
ajlm-2723	15	2	99.99%	PERCENT
ajlm-2723	16	1	0.001	CARDINAL
ajlm-2723	17	1	350 ml	QUANTITY
ajlm-2723	17	2	11.6%	PERCENT
ajlm-2723	17	3	40	CARDINAL
ajlm-2723	17	4	1.1%	PERCENT
ajlm-2723	17	5	3/260	CARDINAL
ajlm-2723	17	6	450 ml	QUANTITY
ajlm-2723	18	1	0.001	CARDINAL
ajlm-2723	18	2	0.215	CARDINAL
ajlm-2723	19	1	fresenius	ORG
ajlm-2723	19	2	macopharma	PERSON
ajlm-2723	19	3	0.001	CARDINAL
ajlm-2723	23	1	ecs	ORG
ajlm-2723	27	1	one	CARDINAL
ajlm-2723	27	2	the 1990s	DATE
ajlm-2723	27	3	creutzfeldt-jakob	ORG
ajlm-2723	27	4	the united kingdom	GPE
ajlm-2723	28	1	france	GPE
ajlm-2723	28	2	i/ii	PRODUCT
ajlm-2723	28	3	3–4	CARDINAL
ajlm-2723	28	4	99.9%	PERCENT
ajlm-2723	28	5	99.99%	PERCENT
ajlm-2723	28	6	1st	ORDINAL
ajlm-2723	28	7	2nd	ORDINAL
ajlm-2723	28	8	90%	PERCENT
ajlm-2723	29	1	ec	ORG
ajlm-2723	29	2	india	GPE
ajlm-2723	30	1	india	GPE
ajlm-2723	32	1	mumbai	GPE
ajlm-2723	32	2	india	GPE
ajlm-2723	33	1	ecs	ORG
ajlm-2723	33	2	two	CARDINAL
ajlm-2723	34	1	mumbai	GPE
ajlm-2723	34	2	india	GPE
ajlm-2723	34	3	900713	DATE
ajlm-2723	34	4	institutional ethics committee	ORG
ajlm-2723	34	5	566/2020	CARDINAL
ajlm-2723	34	6	19	CARDINAL
ajlm-2723	38	1	leukoreduction qc records	ORG
ajlm-2723	38	2	ecs	GPE
ajlm-2723	38	3	01 january 2015 to	DATE
ajlm-2723	38	4	december 2019	DATE
ajlm-2723	38	5	mumbai	GPE
ajlm-2723	38	6	india	GPE
ajlm-2723	40	1	ec	ORG
ajlm-2723	40	2	india	GPE
ajlm-2723	40	3	india	GPE
ajlm-2723	41	1	indian	NORP
ajlm-2723	41	2	1%	PERCENT
ajlm-2723	41	3	ecs	ORG
ajlm-2723	41	4	350 ml	QUANTITY
ajlm-2723	41	5	450 ml	QUANTITY
ajlm-2723	43	1	01 january 2015	DATE
ajlm-2723	43	2	31	CARDINAL
ajlm-2723	43	3	2019	DATE
ajlm-2723	43	4	ecs	ORG
ajlm-2723	43	5	qc	GPE
ajlm-2723	43	6	5-year	DATE
ajlm-2723	44	1	ec	ORG
ajlm-2723	45	1	bd sciences	ORG
ajlm-2723	45	2	mumbai	GPE
ajlm-2723	45	3	maharashtra	GPE
ajlm-2723	45	4	india	GPE
ajlm-2723	45	5	siemens advia	ORG
ajlm-2723	45	6	2120i	DATE
ajlm-2723	45	7	siemens ag	ORG
ajlm-2723	45	8	erlangen	ORG
ajlm-2723	45	9	germany	GPE
ajlm-2723	45	10	5	CARDINAL
ajlm-2723	47	1	ecs	ORG
ajlm-2723	48	1	siemens advia®	ORG
ajlm-2723	49	1	qc	LOC
ajlm-2723	49	2	rbc	ORG
ajlm-2723	49	3	haemoglobin	PERSON
ajlm-2723	49	4	mcv	FAC
ajlm-2723	50	1	paul marienfeld gmbh & co.	ORG
ajlm-2723	50	2	lauda-königshofen	PERSON
ajlm-2723	50	3	germany	GPE
ajlm-2723	51	1	qc	GPE
ajlm-2723	52	1	two	CARDINAL
ajlm-2723	52	2	macopharma leucolab lcg2b:	PERSON
ajlm-2723	52	3	macopharma	PERSON
ajlm-2723	52	4	france	GPE
ajlm-2723	52	5	fresenius	ORG
ajlm-2723	52	6	fresenius kabi ag	ORG
ajlm-2723	52	7	homburg	GPE
ajlm-2723	52	8	germany	GPE
ajlm-2723	52	9	wbc	CARDINAL
ajlm-2723	54	1	microsoft	ORG
ajlm-2723	54	2	redmond	GPE
ajlm-2723	54	3	washington	GPE
ajlm-2723	54	4	united states	GPE
ajlm-2723	55	1	ibm	ORG
ajlm-2723	55	2	24.0	CARDINAL
ajlm-2723	55	3	ibm corp.	ORG
ajlm-2723	55	4	armonk	GPE
ajlm-2723	55	5	new york	GPE
ajlm-2723	55	6	united states	GPE
ajlm-2723	58	1	mann	ORG
ajlm-2723	59	1	0.05	CARDINAL
ajlm-2723	59	2	500	CARDINAL
ajlm-2723	59	3	leukoreduction qc records	ORG
ajlm-2723	59	4	ecs	ORG
ajlm-2723	59	5	34	CARDINAL
ajlm-2723	60	1	52%	PERCENT
ajlm-2723	60	2	450 ml	QUANTITY
ajlm-2723	60	3	350 ml	QUANTITY
ajlm-2723	61	1	69.2%	PERCENT
ajlm-2723	61	2	346/500	CARDINAL
ajlm-2723	61	3	ecs	ORG
ajlm-2723	61	4	macopharma leucolab lcg2b	PERSON
ajlm-2723	61	5	30.8%	PERCENT
ajlm-2723	61	6	154/500	CARDINAL
ajlm-2723	61	7	fresenius	ORG
ajlm-2723	62	1	ecs	ORG
ajlm-2723	62	2	macopharma	PERSON
ajlm-2723	62	3	53.8%	PERCENT
ajlm-2723	63	1	fresenius	ORG
ajlm-2723	63	2	ecs	ORG
ajlm-2723	63	3	350 ml	QUANTITY
ajlm-2723	63	4	48.1%	PERCENT
ajlm-2723	63	5	450 ml	QUANTITY
ajlm-2723	63	6	51.9%	PERCENT
ajlm-2723	64	1	12.4	CARDINAL
ajlm-2723	64	2	0.6	CARDINAL
ajlm-2723	64	3	ec	ORG
ajlm-2723	65	1	approximately 97.2%	PERCENT
ajlm-2723	65	2	± 6.0%	PERCENT
ajlm-2723	66	1	0.001	CARDINAL
ajlm-2723	68	1	54.9	CARDINAL
ajlm-2723	68	2	50.3–63.7	CARDINAL
ajlm-2723	69	1	62.5	CARDINAL
ajlm-2723	69	2	0.001	CARDINAL
ajlm-2723	70	1	ec	ORG
ajlm-2723	70	2	0.001	CARDINAL
ajlm-2723	72	1	47.5	CARDINAL
ajlm-2723	74	1	55.3	CARDINAL
ajlm-2723	75	1	0.001	CARDINAL
ajlm-2723	76	1	the qc criteria	ORG
ajlm-2723	76	2	india	GPE
ajlm-2723	76	3	11.6%	PERCENT
ajlm-2723	76	4	40	CARDINAL
ajlm-2723	76	5	european	NORP
ajlm-2723	76	6	united kingdom	GPE
ajlm-2723	76	7	guidelines).11	DATE
ajlm-2723	76	8	only 1.1%	PERCENT
ajlm-2723	76	9	3/260	CARDINAL
ajlm-2723	77	1	0.001	CARDINAL
ajlm-2723	77	2	0.215	CARDINAL
ajlm-2723	77	3	1	CARDINAL
ajlm-2723	78	1	1	CARDINAL
ajlm-2723	78	2	mumbai	GPE
ajlm-2723	78	3	india	GPE
ajlm-2723	78	4	01 january 2015 to	DATE
ajlm-2723	78	5	2019	DATE
ajlm-2723	79	1	0.001	CARDINAL
ajlm-2723	79	2	mcv	FAC
ajlm-2723	79	3	0.001	CARDINAL
ajlm-2723	81	1	rbc	ORG
ajlm-2723	81	2	haematocrit	ORG
ajlm-2723	81	3	1	CARDINAL
ajlm-2723	82	1	1	CARDINAL
ajlm-2723	82	2	haemoglobin	ORG
ajlm-2723	82	3	mumbai	GPE
ajlm-2723	82	4	india	GPE
ajlm-2723	82	5	01 january 2015 to	DATE
ajlm-2723	82	6	2019	DATE
ajlm-2723	83	1	rbc	ORG
ajlm-2723	83	2	2	CARDINAL
ajlm-2723	84	1	ecs	ORG
ajlm-2723	85	1	rbc	ORG
ajlm-2723	86	1	2	CARDINAL
ajlm-2723	86	2	two	CARDINAL
ajlm-2723	86	3	mumbai	GPE
ajlm-2723	86	4	india	GPE
ajlm-2723	86	5	01 january 2015 to	DATE
ajlm-2723	86	6	2019	DATE
ajlm-2723	87	1	3–4	CARDINAL
ajlm-2723	87	2	5	CARDINAL
ajlm-2723	87	3	106	CARDINAL
ajlm-2723	88	1	only 33.4%	PERCENT
ajlm-2723	88	2	167/500	CARDINAL
ajlm-2723	88	3	1	CARDINAL
ajlm-2723	88	4	106	CARDINAL
ajlm-2723	89	1	fresenius	ORG
ajlm-2723	90	1	macopharma	PERSON
ajlm-2723	90	2	76	CARDINAL
ajlm-2723	90	3	186	CARDINAL
ajlm-2723	90	4	450 ml	QUANTITY
ajlm-2723	90	5	56	CARDINAL
ajlm-2723	90	6	160	CARDINAL
ajlm-2723	90	7	350 ml	QUANTITY
ajlm-2723	91	1	ecs	ORG
ajlm-2723	91	2	fresenius	ORG
ajlm-2723	91	3	17	CARDINAL
ajlm-2723	91	4	80	CARDINAL
ajlm-2723	91	5	450 ml	QUANTITY
ajlm-2723	91	6	18	CARDINAL
ajlm-2723	91	7	74	CARDINAL
ajlm-2723	91	8	450 ml	QUANTITY
ajlm-2723	93	1	two	CARDINAL
ajlm-2723	93	2	0.88	CARDINAL
ajlm-2723	93	3	0.193	CARDINAL
ajlm-2723	93	4	0.001	CARDINAL
ajlm-2723	93	5	2	CARDINAL
ajlm-2723	93	6	3	CARDINAL
ajlm-2723	94	1	2	CARDINAL
ajlm-2723	94	2	mumbai	GPE
ajlm-2723	94	3	india	GPE
ajlm-2723	94	4	01 january 2015 to	DATE
ajlm-2723	94	5	2019	DATE
ajlm-2723	95	1	3	CARDINAL
ajlm-2723	95	2	two	CARDINAL
ajlm-2723	95	3	mumbai	GPE
ajlm-2723	95	4	india	GPE
ajlm-2723	95	5	01 january 2015 to	DATE
ajlm-2723	95	6	2019	DATE
ajlm-2723	96	1	0.343	CARDINAL
ajlm-2723	97	1	ecs	ORG
ajlm-2723	97	2	fresenius	ORG
ajlm-2723	97	3	macopharma	PERSON
ajlm-2723	97	4	0.001	CARDINAL
ajlm-2723	97	5	4	CARDINAL
ajlm-2723	98	1	4	CARDINAL
ajlm-2723	98	2	two	CARDINAL
ajlm-2723	98	3	mumbai	GPE
ajlm-2723	98	4	india	GPE
ajlm-2723	98	5	01 january 2015 to	DATE
ajlm-2723	98	6	2019	DATE
ajlm-2723	99	1	less than 5	CARDINAL
ajlm-2723	101	1	11.6%	PERCENT
ajlm-2723	101	2	28/240	ORDINAL
ajlm-2723	101	3	40	CARDINAL
ajlm-2723	101	4	european	NORP
ajlm-2723	101	5	united kingdom	GPE
ajlm-2723	101	6	guidelines).11	DATE
ajlm-2723	102	1	only 1.1%	PERCENT
ajlm-2723	102	2	3/260	CARDINAL
ajlm-2723	104	1	mcv	FAC
ajlm-2723	105	1	ecs	ORG
ajlm-2723	106	1	two	CARDINAL
ajlm-2723	108	1	ecs undergoing leukoreduction	ORG
ajlm-2723	108	2	fresenius	ORG
ajlm-2723	108	3	macopharma	PERSON
ajlm-2723	109	1	india	GPE
ajlm-2723	109	2	202112	CARDINAL
ajlm-2723	109	3	202213	DATE
ajlm-2723	110	1	two	CARDINAL
ajlm-2723	110	2	indian	NORP
ajlm-2723	110	3	2014	DATE
ajlm-2723	110	4	2023	CARDINAL
ajlm-2723	110	5	less than 40	CARDINAL
ajlm-2723	110	6	450 ml	QUANTITY
ajlm-2723	112	1	two	CARDINAL
ajlm-2723	112	2	indian	NORP
ajlm-2723	112	3	dubey	PERSON
ajlm-2723	112	4	2014,15	CARDINAL
ajlm-2723	112	5	american	NORP
ajlm-2723	113	1	1997,7	CARDINAL
ajlm-2723	113	2	rbc	ORG
ajlm-2723	114	1	mcv	LOC
ajlm-2723	114	2	chinese	NORP
ajlm-2723	115	1	201116	DATE
ajlm-2723	115	2	egyptian	NORP
ajlm-2723	115	3	2016	CARDINAL
ajlm-2723	115	4	mahmoud	PERSON
ajlm-2723	115	5	italian	NORP
ajlm-2723	116	1	2016	CARDINAL
ajlm-2723	116	2	two	CARDINAL
ajlm-2723	116	3	first	ORDINAL
ajlm-2723	116	4	ecs	ORG
ajlm-2723	116	5	mcv	LOC
ajlm-2723	117	1	mcv	LOC
ajlm-2723	117	2	ecs	ORG
ajlm-2723	118	1	mcv	LOC
ajlm-2723	118	2	canadian	NORP
ajlm-2723	118	3	2005	DATE
ajlm-2723	118	4	iran	GPE
ajlm-2723	118	5	2017	DATE
ajlm-2723	120	1	antonelou et al	PERSON
ajlm-2723	120	2	greece	GPE
ajlm-2723	120	3	2012	DATE
ajlm-2723	121	1	chinese	NORP
ajlm-2723	121	2	rbc	ORG
ajlm-2723	121	3	1	CARDINAL
ajlm-2723	121	4	french	NORP
ajlm-2723	121	5	1988	DATE
ajlm-2723	121	6	andreu et al	PERSON
ajlm-2723	121	7	1	CARDINAL
ajlm-2723	121	8	ecs	ORG
ajlm-2723	121	9	american	NORP
ajlm-2723	121	10	heaton et al	ORG
ajlm-2723	122	1	1994	DATE
ajlm-2723	122	2	netherlands	GPE
ajlm-2723	122	3	1993	DATE
ajlm-2723	122	4	two	CARDINAL
ajlm-2723	122	5	indian	NORP
ajlm-2723	123	1	2014	DATE
ajlm-2723	123	2	american	NORP
ajlm-2723	123	3	heaton et al	ORG
ajlm-2723	124	1	1994.15,19	CARDINAL
ajlm-2723	124	2	33.4%	PERCENT
ajlm-2723	124	3	5	CARDINAL
ajlm-2723	125	1	1	CARDINAL
ajlm-2723	125	2	5	CARDINAL
ajlm-2723	127	1	ecs	ORG
ajlm-2723	127	2	macopharma	PERSON
ajlm-2723	127	3	10.3%	PERCENT
ajlm-2723	127	4	± 3.5%	PERCENT
ajlm-2723	127	5	fresenius	ORG
ajlm-2723	127	6	9.56%	PERCENT
ajlm-2723	127	7	± 2.72%	PERCENT
ajlm-2723	128	1	less than 15%	PERCENT
ajlm-2723	128	2	approximately 4.4%	PERCENT
ajlm-2723	128	3	15%	PERCENT
ajlm-2723	129	1	national qc guidelines	ORG
ajlm-2723	129	2	75%	PERCENT
ajlm-2723	130	1	andreu et al.	PERSON
ajlm-2723	131	1	1988	DATE
ajlm-2723	132	1	the united states	GPE
ajlm-2723	132	2	1997.7,8	CARDINAL
ajlm-2723	133	1	fresenius	ORG
ajlm-2723	133	2	macopharma	PERSON
ajlm-2723	134	1	netherlands	GPE
ajlm-2723	134	2	pietersz	GPE
ajlm-2723	134	3	1993.21	CARDINAL
ajlm-2723	137	1	first	ORDINAL
ajlm-2723	137	2	indian	NORP
ajlm-2723	137	3	two	CARDINAL
ajlm-2723	140	1	qc	LOC
ajlm-2723	141	1	ec	ORG
ajlm-2723	146	1	450 ml	QUANTITY
ajlm-2723	149	1	md immuno	GPE
ajlm-2723	149	2	the homi bhabha national institute	ORG
ajlm-2723	149	3	mumbai	GPE
ajlm-2723	149	4	india	GPE
ajlm-2723	149	5	2021	CARDINAL
ajlm-2723	149	6	dr shashank ojha	PERSON
ajlm-2723	151	1	s.o.	GPE
ajlm-2723	152	1	a.n.	PERSON
ajlm-2723	152	2	k.c.	GPE
ajlm-2723	153	1	d.m.	PERSON
ajlm-2723	153	2	k.c.	GPE
ajlm-2723	153	3	s.o.	PERSON
ajlm-2723	154	1	d.m.	GPE
ajlm-2723	154	2	s.o.	GPE
ajlm-2723	154	3	a.n.	GPE
ajlm-2723	154	4	k.c.	GPE
ajlm-2723	155	1	d.m.	PERSON
ajlm-2723	159	1	wy	GPE
ajlm-2723	159	2	al-moshary ma	PERSON
ajlm-2723	163	1	https://doi.org/10.1016/s1658-3876(08)50042-2 harris sb	PERSON
ajlm-2723	163	2	hillyer	PERSON
ajlm-2723	166	1	edinburgh	GPE
ajlm-2723	166	2	churchill livingstone	PERSON
ajlm-2723	166	3	2008	DATE
ajlm-2723	167	1	183–202	CARDINAL
ajlm-2723	168	1	bordin jo	PERSON
ajlm-2723	171	1	patidar gk	PERSON
ajlm-2723	171	2	lakshmy	PERSON
ajlm-2723	171	3	talwar s	PERSON
ajlm-2723	171	4	hazarika a.	PERSON
ajlm-2723	172	1	transfus med	ORG
ajlm-2723	173	1	2020;30(6):497–504	CARDINAL
ajlm-2723	174	1	tzounakas vl	PERSON
ajlm-2723	174	2	stamoulis ke	PERSON
ajlm-2723	174	3	kriebardis ag	ORG
ajlm-2723	174	4	papassideri	ORG
ajlm-2723	178	1	sharma rr	PERSON
ajlm-2723	178	2	marwaha n.	ORG
ajlm-2723	179	1	asian	NORP
ajlm-2723	179	2	j transfus sci.	PERSON
ajlm-2723	181	1	elfath md	GPE
ajlm-2723	181	2	popovsky ma	PERSON
ajlm-2723	182	1	vox	ORG
ajlm-2723	183	1	1997;72(2):101–106	CARDINAL
ajlm-2723	184	1	https://doi.org/10.1046/j.1423-0410.1997.7220101.x andreu g	PERSON
ajlm-2723	184	2	leberre	ORG
ajlm-2723	186	1	1988;72(3):964–969	CARDINAL
ajlm-2723	186	2	hajati e	ORG
ajlm-2723	186	3	goodarzi a.	PERSON
ajlm-2723	186	4	rbc	ORG
ajlm-2723	188	1	2018;12(1):35–42	DATE
ajlm-2723	188	2	mahmoud rh	PERSON
ajlm-2723	188	3	hassan da	PERSON
ajlm-2723	189	1	clin med diagn	ORG
ajlm-2723	191	1	https://doi.org/10.5923/j.cmd.20160604.01 council of europe	ORG
ajlm-2723	192	1	no.r	ORG
ajlm-2723	192	2	95	CARDINAL
ajlm-2723	192	3	15	CARDINAL
ajlm-2723	193	1	20th	ORDINAL
ajlm-2723	193	2	strasbourg: council of europe	ORG
ajlm-2723	193	3	2020	DATE
ajlm-2723	194	1	biswas ak	ORG
ajlm-2723	194	2	baranwal ak	ORG
ajlm-2723	194	3	philip j. comparative study	PERSON
ajlm-2723	194	4	nageotte hemocytometry	PERSON
ajlm-2723	195	1	asian	NORP
ajlm-2723	195	2	j transfus sci	PERSON
ajlm-2723	196	1	2023;17(1):63–68	CARDINAL
ajlm-2723	196	2	https://doi.org/10.4103/ajts.ajts_101_21	ORG
ajlm-2723	196	3	mittal s	ORG
ajlm-2723	196	4	chacko mp	PERSON
ajlm-2723	196	5	varughese	PERSON
ajlm-2723	200	1	https://doi.org/10.1111/trf.16570 chand s	ORG
ajlm-2723	200	2	rudrappan	GPE
ajlm-2723	200	3	gupta d.	PERSON
ajlm-2723	201	1	asian	NORP
ajlm-2723	201	2	j transfus sci	PERSON
ajlm-2723	202	1	2023;17(2):151–156	CARDINAL
ajlm-2723	203	1	https://doi.org/10.4103/ajts.ajts_126_21	NORP
ajlm-2723	203	2	chaudhary r. evaluation	PERSON
ajlm-2723	204	1	indian	NORP
ajlm-2723	205	1	2014;30(4):321–327	CARDINAL
ajlm-2723	206	1	https://doi.org/10.1007/s12288-013-0257-0	PERSON
ajlm-2723	206	2	hao p	PERSON
ajlm-2723	206	3	xiao y	PERSON
ajlm-2723	206	4	zhao j	PERSON
ajlm-2723	206	5	li z.	PERSON
ajlm-2723	206	6	rbc	ORG
ajlm-2723	207	1	plos	PERSON
ajlm-2723	208	1	2011;6(3):e18328	CARDINAL
ajlm-2723	209	1	baroni f	PERSON
ajlm-2723	209	2	berni p	PERSON
ajlm-2723	210	1	mol biosci	PERSON
ajlm-2723	211	1	2016;3:13	CARDINAL
ajlm-2723	212	1	https://doi.org/10.3389/fmolb.2016.00013 gyongyossy-issa mi	PERSON
ajlm-2723	212	2	weiss sl	PERSON
ajlm-2723	213	1	devine dv	PERSON
ajlm-2723	215	1	2005;45(1):90–96	CARDINAL
ajlm-2723	215	2	https://doi.org/10.1111/j.1537-2995.2005.04061.x heaton wa	PERSON
ajlm-2723	215	3	holme s	PERSON
ajlm-2723	215	4	smith k	PERSON
ajlm-2723	215	5	3-5 log10	QUANTITY
ajlm-2723	216	1	j haematol	PERSON
ajlm-2723	217	1	1994;87(2):363–368	CARDINAL
ajlm-2723	218	1	prins hk	ORG
ajlm-2723	218	2	biewenga j. mechanisms	PERSON
ajlm-2723	221	1	https://doi.org/10.1046/j.1537-2995.1993.33193142309.x pietersz rn	PERSON
ajlm-2723	223	1	transfus med rev	ORG